Gait and Balance Impairment in Rare and Very Rare Neurological Diseases (GALVANISE)
Sponsor: IRCCS Istituto Neurologico Carlo Besta
A observational or N/A phase clinical study on Healthy and Healthy Aging, this trial is actively recruiting participants. The trial is conducted by IRCCS Istituto Neurologico Carlo Besta and has accumulated 4 data snapshots since 2023. Longitudinal tracking of this trial contributes to a broader understanding of treatment development timelines.
Status Flow
Change History
4 versions recorded-
Sep 2025 — Present [monthly]
Recruiting
-
Sep 2024 — Sep 2025 [monthly]
Recruiting
-
Jul 2024 — Sep 2024 [monthly]
Recruiting
-
May 2024 — Jul 2024 [monthly]
Recruiting
First recorded
May 2023
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- IRCCS Istituto Neurologico Carlo Besta
- Istituto Auxologico Italiano
For direct contact, visit the study record on ClinicalTrials.gov .